Let new medical productivity be integrated into the “double first-class” discipline construction: Tongji University Cancer Center is launched

Release time:May 25, 2024 16:16 PM

The reporter learned from China’s first CELLplus academic forum that Tongji University Cancer Center was officially launched today. After multiple discussions by experts from all walks of life, on May 23, 2017, Tongji University handed over the main construction unit of the cancer center to the Affiliated Tenth People's Hospital. In the past few years, Tongji University leaders have led teams to the hospital to investigate the cancer center many times, guide and layout the construction of the center, and point out the strategic direction of facing the world's technological frontiers, facing the country's major needs, and facing the people's life and health.

It is reported that while continuing to strengthen standardized diagnosis and treatment of tumors, the 10th hospital has further focused on cell biological immunotherapy. In 2018, it established the first tumor biological therapy ward in Shanghai, and has accumulated CAR-T cells, oncolytic viruses, neoantigen vaccines, NK There have been more than 1,000 cases of cell and TIL cell therapy, and oncolytic virus therapy technology has formed a consensus among experts in China and Shanghai. Also in the same year, the Cancer Cell Therapy Center was approved by the Municipal Science and Technology Commission as the "Shanghai Cancer Cell Therapy Technology Innovation Center", and its "front yard and back factory" model was written into the "Shanghai Action Plan for Promoting Cell Therapy Technology Innovation and Industrial Development."

In July 2020, the hospital's clinical medicine innovation park was officially put into use, carrying the functions of basic research and achievement transformation of the cancer center. The park aims at the functional positioning of achievement transformation and has attracted 1 academician team and 10 scientific research teams to settle in the park. In April 2023, it was approved as a national postdoctoral research workstation; in June of the same year, the Molecular Diagnostic Innovation Technology Research Institute of the Shanghai Institute of Experimental Medicine was established.

According to the person in charge of the center, as another important support for the construction of the Tongji University Cancer Center, with the care and support of Tongji University, the Municipal Health Commission and the Shenkang Hospital Development Center, the Tenth Affiliated Hospital’s Cancer Precision Diagnosis and Treatment Center project has been approved by the Municipal Development and Reform Commission. Approval. In the future, the hospital will further improve the oncology diagnosis and treatment facilities, optimize the functional layout and diagnosis and treatment process of the hospital area, and build a truly patient-centered, one-stop comprehensive diagnosis and treatment center for cancer patients; strengthen the basic and clinical talent training of oncology disciplines, and build a "Tongji University" A disciplinary highland matching “Double First-class”; striving to become a national cancer regional medical center and a domestic first-class and internationally renowned precision cancer diagnosis and treatment center.


Let new medical productivity be integrated into the “double first-class” discipline construction: Tongji University Cancer Center is launched
comment
Joint layout of early basic scientific research on digital medicine, school-enterprise cooperation
Joint layout of early basic scientific research on digital medicine, school-enterprise cooperation

Recently, the Institute of Intelligent Medicine of Fudan University and Takeda Pharmaceutical signed a memorandum of cooperation. Both parties will give full play to their own advantages, promote early basic research and changes in the digital medical industry, and carry out innovative research and concepts from screening, diagnosis to companion treatment. Establish models and accelerate the commercialization of breakthrough results based on an evidence-based ecosystem. In recent years, the structure of the pharmaceutical industry has been reshaped and digital medical technology has been developing rapidly. my country's biopharmaceutical industry has ushered in an opportunity for change. In July this year, Shanghai released the "Shanghai Biomedical Industry Digital Transformation Implementation Plan" to comprehensively and in-depth support the digital transformation of the biomedical industry. Digital technology is a key element in promoting sustainable development of enterprises. Takeda Pharmaceuticals’ recent clinical trial leverages digital capabilities to integrate patients and operations

How to "escort" health, National Healthy Lifestyle Action Day | diabetes patients travel
How to "escort" health, National Healthy Lifestyle Action Day | diabetes patients travel

Today is the 17th National Healthy Lifestyle Action Day, which has become an important focus for the prevention and control of chronic diseases and the promotion of healthy lifestyles in China. As one of the major chronic diseases in China, diabetes patients cannot face the "sweet burden" without daily health management. In the golden autumn season, Roche Diagnostics Health Care Department provides seven tips based on different stages of travel before and during travel, giving simple and understandable popular science advice on the carrying and use of equipment, drugs and other items necessary for diabetes patients to travel. Data shows that there are more than 140 million diabetes patients in China. If the blood sugar of diabetes patients is not well controlled for a long time, irreversible complications such as kidney disease, retinopathy, cardiovascular disease will occur. The longer the course of diabetes, the worse the blood sugar control and complications

The 19th Silver Snake Awards of the Shanghai Health System have been announced: 39 outstanding young people stand out in technology | youth | health
The 19th Silver Snake Awards of the Shanghai Health System have been announced: 39 outstanding young people stand out in technology | youth | health

Today, the results of the 19th Silver Snake Awards were officially announced, with 22 outstanding medical youths winning the Silver Snake Awards and 17 medical youths receiving nomination awards. Mr. Shi Zhifeng from the Neurosurgery Department of Huashan Hospital affiliated with Fudan University and Mr. Liu Shen from the Orthopedics Department of Shanghai Sixth People's Hospital won the first prize of the Silver Snake Award this year; Their mentors, Professor Mao Ying from Huashan Hospital and Professor Fan Cunyi from the Sixth People's Hospital, were awarded the Special Honorary Award of the Silver Snake Award. The Silver Snake Award is the highest honor award for young talents in the Shanghai Health System, established in 1989. This award is aimed at outstanding medical young people under the age of 40 in Shanghai and is selected every two years. For over 30 years, the Silver Snake Award has played an extremely important role in exploring and cultivating outstanding medical young talents in Shanghai, and batches of outstanding young people have stood out on this platform. section

Shanghai independently develops the first domestic universal quadrivalent influenza virus split vaccine for people aged 6 months and above, initiating influenza vaccination | vaccination | universal
Shanghai independently develops the first domestic universal quadrivalent influenza virus split vaccine for people aged 6 months and above, initiating influenza vaccination | vaccination | universal

Shanghai's independently developed domestic first universal quadrivalent influenza virus split vaccine for people aged 6 months and above has recently launched vaccination in Shanghai. It is expected to be promoted throughout the city by the end of August, providing citizens with an additional option to prevent influenza. It is reported that this vaccine independently developed by Shanghai Biotechnology is the first universal quadrivalent influenza virus split vaccine for people aged 6 months and above in China. It was approved by the National Medical Products Administration for marketing on November 22, last year. The vaccine has achieved unified dosage forms for infants, adolescents, adults, and the elderly for the first time in China, becoming the first exclusive universal quadrivalent influenza vaccine for all age groups in the country. At the Tianlin Community Health Service Center in Xuhui District, the first batch of vaccination sites, Ms. Yang and her family of three generations completed the vaccination. "I heard that babies under 3 years old can also receive full dose influenza vaccine, so make an appointment as soon as possible."

Shanghai has a group of "science popularization artists": 20 "emerging figures" appear in the first Health Science Popularization Selection Tree Activity, a group of | contributions | characters
Shanghai has a group of "science popularization artists": 20 "emerging figures" appear in the first Health Science Popularization Selection Tree Activity, a group of | contributions | characters

"The future of health science popularization is the dancing of health knowledge and various arts; integrating hard work into works, firmly grasping health; hoping to be remembered by you, me, and him, remember this group of science popularization artists." At the first Shanghai Health Science Popularization Promotion Tree Selection Activity, Liu Feng from the Jiading District Center for Disease Control and Prevention brought a self edited rap of "Science Popularization Artist", adding another spark to the atmosphere at the scene. 20 "emerging figures" candidates appeared one by one, sharing their recent actions, thoughts, and feelings in the field of health science popularization. In order to further build the "main battlefield" of health science popularization in medical institutions, continuously strengthen the role of medical personnel as the "main force" of health science popularization, encourage and publicize individuals and institutions that have made outstanding contributions to health science popularization, and mobilize the initiative and accumulation of all sectors of society to participate in health science popularization work and health promotion services